Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 23
Filter
1.
Neuropediatrics ; 26(1): 45-50, 1995 Feb.
Article in English | MEDLINE | ID: mdl-7791951

ABSTRACT

In a retrospective study the results of therapy in 60 children with so-called benign partial epilepsies are reported. It has been shown that the assessment of the therapeutic effect has to include the EEG, especially in epilepsies with atypical course. Carbamazepine has no effect on the EEG, in epilepsies with atypical course (atypical benign partial epilepsy, Landau-Kleffner syndrome, epilepsy with continuous spikes and waves during slow sleep [CSWS]) carbamazepine usually has no effect either on the seizures or on the EEG, on the contrary, in some cases both may even get worse. In our experience, the drug of choice in all types of benign childhood epilepsy is sulthiame, if necessary in combination with clobazam. Other drugs previously administered, including carbamazepine, should be dropped quickly. If the treatment with sulthiame or sulthiame/clobazam in children with atypical course is not effective, ACTH-therapy should be considered as soon as possible. These results should be confirmed in a prospective randomized study.


Subject(s)
Adrenocorticotropic Hormone/therapeutic use , Anti-Anxiety Agents , Anticonvulsants , Benzodiazepines , Benzodiazepinones/therapeutic use , Carbamazepine/therapeutic use , Epilepsies, Partial/drug therapy , Phenytoin/therapeutic use , Primidone/therapeutic use , Thiazines/therapeutic use , Brain/physiopathology , Child , Child, Preschool , Clobazam , Electroencephalography , Epilepsies, Partial/diagnosis , Epilepsies, Partial/physiopathology , Humans , Sleep, REM , Treatment Outcome
2.
Epilepsia ; 35(5): 1005-15, 1994.
Article in English | MEDLINE | ID: mdl-7925143

ABSTRACT

Since our last report on valproate (VPA)-related hepatotoxicity in 1988, 8 other children have died of VPA-associated liver failure in Germany and Switzerland. We compared the clinical course of these children with that of 6 children with a reversible outcome of severe hepatotoxicity related to VPA. Thirty-five percent of patients with fatal liver failure were normally developed, 23.5% were receiving VPA monotherapy, and 35.3% were aged < or = 2 years. The initial clinical symptoms of VPA-related hepatotoxicity were nausea, vomiting, apathy or coma, and increasing seizures in more than 50% of patients, in combination with febrile infections at onset of symptoms. As compared with the series of German patients reported in 1988, one third of the fatalities occurred after the first 6 months of therapy as compared with 6% in the 1988 series. Clinical symptoms and laboratory findings were the same in patients with reversible and with fatal outcome. Early or immediate withdrawal of VPA after the first signs of VPA-associated hepatotoxicity may be responsible for the increased number of children who recovered after VPA-related severe liver failure. The pathogenesis of liver failure during VPA treatment remains unknown; metabolic defects and cofactors such as polypharmacy or infections have become increasingly likely to contribute by depleting intracellular CoA. Worldwide, 132 patients have died of VPA-associated liver failure and/or pancreatitis. Because a group at risk for fatalities with VPA cannot be defined precisely, patients treated with VPA and their families must be made well aware of the clinical symptoms of hepatotoxicity such as apathy, vomiting, or increased seizure frequency, especially in the presence of febrile infections. Laboratory tests and clinical controls during the first 6 months of therapy should not be neglected.


Subject(s)
Epilepsy/drug therapy , Liver Failure/chemically induced , Liver Failure/mortality , Valproic Acid/adverse effects , Adult , Age Distribution , Anticonvulsants/therapeutic use , Carnitine/therapeutic use , Child , Child, Preschool , Comorbidity , Drug Therapy, Combination , Female , Germany/epidemiology , Humans , Incidence , Infant , Infections/epidemiology , Liver Failure/epidemiology , Male , Pancreatitis/epidemiology , Pancreatitis/mortality , Sex Distribution , Switzerland/epidemiology , Time Factors , Valproic Acid/therapeutic use
4.
Monatsschr Kinderheilkd ; 140(8): 451-6, 1992 Aug.
Article in German | MEDLINE | ID: mdl-1435803

ABSTRACT

Idiopathic epilepsies with generalized seizures of early childhood are based on a genetic predisposition. The onset takes place between the first and fifth years of age, boys are affected more often than girls. Dependent on the clinical symptomatology you have to distinguish: myoclonic seizures; atonic-astatic seizures; myoclonic-astatic seizures; absences; tonic-clonic seizures. In more than half of the cases a combination of these seizures can be observed. The differentiation of epilepsies with generalized seizures of multifocal origin (infantile spasms, Lennox-Gastaut syndrome and Pseudo-Lennox syndrome [atypical benign epilepsy]) may be difficult but is essential. Therapy of choice is valproate, often in combination with ethosuximide (in children with minor seizures) or with kaliumbromide or phenobarbital (in children with tonic-clonic seizures). Generally the prognosis is more unfavourable if epilepsy starts in the first year of life with afebrile and febrile generalized tonic-clonic or clonic seizures, if children are suffering from longlasting states of seizures and if development is disturbed before beginning of epilepsy.


Subject(s)
Epilepsy, Generalized/etiology , Spasms, Infantile/etiology , Anticonvulsants/therapeutic use , Child, Preschool , Diagnosis, Differential , Drug Therapy, Combination , Electroencephalography/drug effects , Epilepsy, Generalized/diagnosis , Epilepsy, Generalized/drug therapy , Follow-Up Studies , Humans , Infant , Spasms, Infantile/diagnosis , Spasms, Infantile/drug therapy
8.
Neuropadiatrie ; 9(4): 303-11, 1978 Nov.
Article in English | MEDLINE | ID: mdl-581786

ABSTRACT

Investigations of galvanic skin response under stress by different stimuli were carried out in 65 photosensitive and 70 non-photosensitive subjects aged 11--17 years. Photosensitive individuals at the age of 12--15 years showed a more pronounced skin reaction than non-photosensitive ones. The emotional reagibility (expressed by IE = (SEE TEXT), Traxel 1960, Stocksmeier and Langosch 1973) shows significantly higher values than in nonphotosensitive children. In addition to this, photosensitive subjects demonstrate a delayed habituation. Together with further results (Gross-Selbeck et al. 1976) the findings indicate that photosensitivity is not the isolated symptom of a genetically determined increased cerebral excitability, which can represent a factor in the pathogenesis of epilepsy for instance, but must be understood as a special characteristic of a particular constitution.


Subject(s)
Brain/physiology , Galvanic Skin Response , Photosensitivity Disorders/physiopathology , Adolescent , Child , Electroencephalography , Epilepsy/genetics , Epilepsy/physiopathology , Female , Humans , Male
9.
Eur Neurol ; 17(3): 129-35, 1978.
Article in English | MEDLINE | ID: mdl-95951

ABSTRACT

A 5-year-old boy is reported with spinal myoclonus caused by cervical astrocytoma due to neurofibromatosis. The essential clinical and electromyographical signs of spinal myoclonus are the following: (1) Continuous rhythmical appearance in muscles innervated by the affected segments of the spinal cord. (2) Synchronous myoclonus in muscles innervated by the same spinal segments of one body side, asynchronous myoclonus in muscles of different segments as well as in contralateral muscles of the same segments. (3) Usually stable frequency, which may increase to a manifold under the influence of different stimuli. (4) Accentuation of the myoclonus under mental distress, disappearance during deeper sleep. The pathophysiological basis of spinal myoclonus might be a disinhibition in the area of the spinal formatio reticularis. Supraspinal stimuli can influence the myoclonus.


Subject(s)
Astrocytoma/complications , Myoclonus , Spinal Cord Diseases , Spinal Cord Neoplasms/complications , Child, Preschool , Electromyography , Humans , Male , Myoclonus/etiology , Neurofibromatosis 1/complications , Spinal Cord Diseases/etiology
10.
Neuropadiatrie ; 8(4): 325-32, 1977 Nov.
Article in English | MEDLINE | ID: mdl-304194

ABSTRACT

20 children with tuberous sclerosis were examined by computertomography (CCT). The test is useful to detect cerebral involvement with great certainty. The method is especially helpful in the early diagnosis of the disease. This offers the possibility of giving an early genetic advice. Characteristic CCT scan abnormalities in tuberous sclerosis are multiple densities in the walls and the roof of lateral ventricles. This specific finding can already be seen prior to the occurrence of calcifications in standard roentgenograms.


Subject(s)
Tomography, X-Ray Computed/methods , Tuberous Sclerosis/diagnostic imaging , Adolescent , Calcinosis/diagnostic imaging , Cerebral Ventriculography , Child , Child, Preschool , Female , Humans , Male , Time Factors , Tuberous Sclerosis/genetics
12.
Eur J Pediatr ; 126(1-2): 13-27, 1977 Aug 23.
Article in English | MEDLINE | ID: mdl-902660

ABSTRACT

The pre- and postnatal clinical, cytogenetic and embryological findings in a family suffering from trisomy 9p and spinal muscular atrophy are presented. The clinical picture of the "trisomy 9p" -syndrome is delineated. Concurrence of autosomal aberration and spinal muscular atrophy, probably of the Werdnig-Hoffmann type, is discussed.


Subject(s)
Chromosomes, Human, 6-12 and X , Muscular Atrophy/genetics , Trisomy , Abortion, Induced , Amniocentesis , Anterior Horn Cells , Autopsy , Child, Preschool , Female , Fetus/pathology , Humans , Karyotyping , Muscular Atrophy/diagnosis , Muscular Atrophy/pathology , Pregnancy , Prenatal Diagnosis
SELECTION OF CITATIONS
SEARCH DETAIL
...